| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.5 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |